Dana Pharmaceuticals Private Limited

Dana Pharmaceuticals Private Limited - pharma in Mumbai, Maharashtra, India. FY 2026 financials and compliance.
CIN U24239MH1996PTC101669 Incorporated 07 August 1996 ROC Mumbai HQ Mumbai, Maharashtra, India
Active Private Limited Company pharma
Data last updated
Revenue · FY 2025
₹1.96 Cr
▼ 78.00% YoY
EBITDA · FY 2025
Locked
In full report
Net profit · FY 2025
Locked
In full report
Authorised capital
₹4.05 Cr
Registered with MCA
Paid-up capital
₹3.81 Cr
Issued & subscribed
Open charges
₹5.05 Cr
Secured borrowings
Company age
30 yrs
Est. 1996
Employees · EPFO
8
Latest available

About Dana Pharmaceuticals Private Limited

Data last updated: 25 February 2026

Dana Pharmaceuticals Private Limited is a private limited company based in Mumbai, Maharashtra, India. It specialises in drug formulation and development, a part of the broader pharmaceuticals sector. Incorporated on 07 August 1996, the company has been in operation for over 30 years.

Registered with ROC Mumbai under CIN U24239MH1996PTC101669.

Capital: an authorised share capital of ₹4.05 Cr and a paid-up capital of ₹3.81 Cr. It is led by directors including Suresh Sagarmal Parmar and Abhai Sachidanand Attavar.

Last AGM: 29 September 2025. Financial statements filed for year ended 31 March 2025. Office: 209 Bhaveshwar Complex Vidyavihar (W) Mumbai – 86., Maharashtra, India.

As per the financials filed for FY 2025, the company reported a revenue of ₹1.96 Cr, a decline of 78% compared to the previous year.

The company has a workforce of approximately 8 employees as per the latest available data.

As per MCA filings, the company has open charges of ₹5.05 Cr on record.

The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website danagroup.com.

Company Details of Dana Pharmaceuticals Private Limited
CIN U24239MH1996PTC101669
Registration Number 101669
Incorporation Date 07 August 1996
ROC Mumbai
Listing Status Unlisted
Company Status Active
Date of Last AGM 29 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
Contact Details
  • Email
    Locked
  • Telephone
    Locked
  • Website
  • Social Media
    Locked
  • Registered Address
    209 Bhaveshwar Complex Vidyavihar (W) Mumbai – 86., Maharashtra, India
  • Industry
    Pharma, Drug Formulation & Development
Company report
Dana Pharmaceuticals Private Limited - full intelligence report
  • Historical Financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Litigation, compliance and MCA filings
  • PDF report delivered after checkout
₹799 ₹999 20% off
Secure checkout · GST invoice included

Unlock the full Dana Pharmaceuticals Private Limited report

Financials, compliance, directors, charges, ownership and filings for Dana Pharmaceuticals Private Limited in one report.

10-year financials Directors & ownership Charges & compliance

CIN History of Dana Pharmaceuticals Private Limited

Dana Pharmaceuticals Private Limited has one previous CIN (Corporate Identification Number): U99999MH1996PTC101669. The current CIN is U24239MH1996PTC101669, which is the unique identifier assigned by the Registrar of Companies.

CIN Status
U24239MH1996PTC101669 Current
U99999MH1996PTC101669 Previous

Business Activity of Dana Pharmaceuticals Private Limited

Dana Pharmaceuticals Private Limited is engaged in the principal business activity of trade, with detailed activities including retail trading.

Main Activity Group Code Description of Main Activity Business Activity Code Description of Business Activity Turnover Percentage
G Trade G2 Retail Trading Locked
Premium access

Business activity turnover details for Dana Pharmaceuticals Private Limited

Turnover contribution percentages and historical activity changes require an active report plan.

  • Turnover contribution
  • Historical classifications
  • Filing-level activity changes

Verified entity values are shown only after access is granted.

Auditor Details of Dana Pharmaceuticals Private Limited

Dana Pharmaceuticals Private Limited is audited by SHAH AND MODI CHARTERED ACCOUNTANTS for the financial year 2023. The auditor plays a crucial role in ensuring financial transparency and compliance with accounting standards.

Name Status Appointment Date Cessation Date
SHAH AND MODI CHARTERED ACCOUNTANTS Locked Locked Locked
Premium access

Complete auditor history for Dana Pharmaceuticals Private Limited

Appointment status, appointment dates, cessation dates, and historical auditor changes require an active report plan.

  • Appointment status
  • Appointment dates
  • Cessation dates
  • Auditor changes

Verified entity values are shown only after access is granted.

Board of Directors of Dana Pharmaceuticals Private Limited

Dana Pharmaceuticals Private Limited is currently managed by 4 directors, with 5 former directors having served the organization. The current Directors play a crucial role in shaping the company's strategic direction and governance.

Current Directors
Name Designation Appointment Date Tenure Status
Suresh Sagarmal Parmar Director 02 Aug 2022 4 Years 0 Months Current
Abhai Sachidanand Attavar Director 02 Aug 2022 4 Years 0 Months Current
Gautam Hathiramani Ramesh Director 07 Aug 1996 30 Years 0 Months Current
Jacky Ramesh Hathiramani Director 07 Aug 1996 30 Years 0 Months Current

Financials of Dana Pharmaceuticals Private Limited FY 2025 filings available

Dana Pharmaceuticals Private Limited reported revenue of ₹1.96 Cr (down 78.00% YoY) for FY 2025.

Revenue · FY 2025
₹1.96 Cr ▼ 78.00%
Premium access

Ten-year financial statements for Dana Pharmaceuticals Private Limited

Historical statement values and trend charts require an active report plan.

  • Income statements
  • Balance sheets
  • Cash-flow statements
  • Ratios and benchmarks

Verified entity values are shown only after access is granted.

Ownership and Shareholding of Dana Pharmaceuticals Private Limited

Premium access

Shareholding and ownership data for Dana Pharmaceuticals Private Limited

Promoter, institutional, public, and beneficial ownership values require an active report plan.

  • Ownership categories
  • Historical changes
  • Group structure
  • FII and DII holdings

Verified entity values are shown only after access is granted.

Charges & Borrowings of Dana Pharmaceuticals Private Limited

Open charges
₹5.05 Cr
Satisfied charges
₹0
Breakdown by lending institutions
Indian Overseas Bank₹5.05 Cr
Latest charge details
DateLenderAmountStatus
26 Mar 2010 Indian Overseas Bank ₹1 Cr Open
28 Mar 2008 Indian Overseas Bank ₹1.8 Cr Open
28 Mar 2008 Indian Overseas Bank ₹50 Lakh Open
15 Oct 1997 Indian Overseas Bank ₹35 Lakh Open
29 Sep 1997 Indian Overseas Bank ₹50 Lakh Open

Total charge records: 6 View all charges

Employees and EPFO Compliance at Dana Pharmaceuticals Private Limited

Dana Pharmaceuticals Private Limited has a workforce of 8 employees as of Apr 01, 2024.

Employee count
8
Active EPFO establishments
1
Employee growth
-11.11%
Premium access

Employee and EPFO history for Dana Pharmaceuticals Private Limited

Monthly headcount, contribution history, establishment records, and filing compliance require an active report plan.

  • Monthly headcount
  • PF contributions
  • ECR filing status
  • Establishment history

Verified entity values are shown only after access is granted.

GST Compliance of Dana Pharmaceuticals Private Limited

Premium access

GST registrations and filing compliance for Dana Pharmaceuticals Private Limited

State-wise registrations, return filing status, HSN and SAC details, and jurisdiction records require an active report plan.

  • GSTIN registrations
  • State-wise filing status
  • HSN and SAC details
  • Tax jurisdiction records

Verified entity values are shown only after access is granted.

Credit Ratings, Litigation & Regulatory Alerts for Dana Pharmaceuticals Private Limited

Premium access

Credit ratings, litigation, and regulatory alerts for Dana Pharmaceuticals Private Limited

Agency ratings, court records, regulatory events, and entity-specific compliance alerts require an active report plan.

  • Rating history
  • Court and tribunal cases
  • Regulatory alerts
  • Director-linked violations

Verified entity values are shown only after access is granted.

MSME Payment Delays by Dana Pharmaceuticals Private Limited

Premium access

MSME payment history for Dana Pharmaceuticals Private Limited

Amounts outstanding to micro and small suppliers, delay reasons, and MSME-1 filing history require an active report plan.

  • Outstanding amounts
  • Delay periods and reasons
  • MSME-1 filing history
  • Vendor payment signals

Verified entity values are shown only after access is granted.

Subsidiaries & Group Companies of Dana Pharmaceuticals Private Limited

Premium access

Corporate group structure for Dana Pharmaceuticals Private Limited

Parent, subsidiary, associate, joint venture, and ownership records require an active report plan.

  • Parent company
  • Subsidiaries and ownership
  • Associates and joint ventures
  • Entity investments

Verified entity values are shown only after access is granted.

MCA Filings & Documents of Dana Pharmaceuticals Private Limited

Premium access

MCA filings and documents for Dana Pharmaceuticals Private Limited

Official forms, annual returns, financial statements, charge filings, and document dates require an active report plan.

  • Incorporation documents
  • Annual returns and statements
  • Charge filings
  • Complete filing index

Verified entity values are shown only after access is granted.

Recent Activity on Dana Pharmaceuticals Private Limited

Activity
29 Sep 2025
Dana Pharmaceuticals Private Limited last Annual general meeting of members was held on 29 Sep 2025 as per latest MCA records.
Activity
31 Mar 2025
Dana Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai I.
Directors
02 Aug 2022
Suresh Sagarmal Parmar was appointed as a Director on 02 Aug 2022 & has been associated with this company since 4 years 23 days.
Directors
02 Aug 2022
Abhai Sachidanand Attavar was appointed as a Director on 02 Aug 2022 & has been associated with this company since 4 years 23 days.
Charges
21 Dec 2017
A charge with Indian Overseas Bank of Rs. 1.00 Cr registered on 26 Mar 2010 with Charge ID 10213566 was modified on 21 Dec 2017.
Charges
26 Mar 2010
A charge with Indian Overseas Bank amounted to Rs. 1.00 Cr with Charge ID 10213566 was registered on 26 Mar 2010.

Frequently Asked Questions about Dana Pharmaceuticals Private Limited

Dana Pharmaceuticals Private Limited is an active private limited company in the pharma sector based in Mumbai, Maharashtra, India. It was incorporated on 07 August 1996 (30+ years old) and is registered under CIN U24239MH1996PTC101669. The company has 8 employees.

Dana Pharmaceuticals Private Limited reported revenue of ₹1.96 Cr for FY 2025 (down 78.00% YoY).

The current directors of Dana Pharmaceuticals Private Limited are:

The primary industry of Dana Pharmaceuticals Private Limited is pharma. The company specifically operates in drug formulation and development. The company is currently active in this sector.

Dana Pharmaceuticals Private Limited can be reached at the registered office: 209 Bhaveshwar Complex Vidyavihar W Mumbai – 86, Maharashtra, India, or through the website danagroup.com.

The authorised capital is ₹4.05 Cr, and the paid-up capital is ₹3.81 Cr.

7M+ Indian companies. One platform.

Financials, directors, compliance, charges and shareholding - sourced from MCA, SEBI and RBI filings.

Subscription plans available